The KID study VI: Diabetic complications and associated diseases in younger type 2 diabetics still performing a profession, prevalence and correlation with duration of diabetic state, BMI and C-peptide

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 7, 1999, Pages 435-441

  Haupt, Ekke ^a,b   Benecke, A ^a   Haupt, A ^a   Herrmann, R ^a   Vogel, H ^a   Walter, C ^a  

^a Saale Klinik der BfA   (Germany)

^b BfA Saale Klinik   (Germany)

Author keywords

Associated disease in type 2 diabetes,; BMI; C peptide; Diabetic complications

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORRELATION FUNCTION; DETERIORATION; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROTEINURIA; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032703483     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212134     Document Type: Review

References (33)

1. Assmann G, Schulte H: The Prospective Cardiovascular Münster (PROCAM) Study: Prevalence of hyperlipidaemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 116: 1713-1724, 1988
2. Ferrannini E, Buzzigoli G, Bonadonna R et al.: Insulin resistance and essential hypertension. N Engl J Med 317: 350-357, 1987
3. Garcia MJ, McNamara PM, Gordin T, Kannell WS: Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23: 105-111, 1974
4. Harris MI, Klein R, Welborn TA, Knuiman MV: Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 15: 815-819, 1992
5. Harris MI: Hypercholesterolaemia in diabetes and glucose intolerance in the U.S. population. Diabetes Care 14: 366-374, 1991
6. Haupt E, Herrmann R, Benecke-Timp A, Vogel H, Hilgenfeldt J, Haupt A, Walter C: The KID Study I: Structural baseline characteristics of the Federal Insurance for Salaried Employees Institution (BfA) diabetic patients in inpatient rehabilitation. Exp Clin Endocrinol Diabetes 104: 370-377, 1996
7. Haupt E, Herrmann R, Benecke-Timp A, Vogel H, Haupt A, Walter C: The KID Study II: Socioeconomic baseline characteristics, psycho-social strain, standard of current medical care and education of the Federal Insurance for Salaried Employees Institution (BfA) diabetic patients in inpatient rehabilitation. Exp Clin Endocrinol Diabetes 104: 378-386, 1996
8. Haupt E, Herrmann R, Benecke-Timp A. Vogel H, Hilgenfeldt J, Haupt A, Walter C: The KID Study III: Impact of inpatient rehabilitation on the metabolic control of type II diabetics - a one-year follow-up. Exp Clin Endocrinol Diabetes 104: 420-430, 1996
9. Haupt E, Herrmann R, Benecke-Timp A, Vogel H, Haupt A, Walter C: The KID Study IV: Effects of inpatient rehabilitation on the frequency of glucose self-monitoring, quality of further primary care, on time being unable to work and on everyday psychic strain of type I and type II diabetics - a one-year follow-up. Exp Clin Endocrinol Diabetes 105: 21-31, 1997
10. Howard BV: Lipoprotein metabolism in diabetes. Curr Opin Lipidol 5: 216-220, 1994
11. Kannel WB, McGree DL: Diabetes and cadiovascular risk factors: The Framingham Study. Circulation 59: 8-13, 1979
12. Löwel H, Stieber J, Koenig W, Thorand B, Hörmann A, Gostomzyk J, Keil U: Das diabetes-bedingte Herzinfarkt-Risiko in einer süddeutschen Bevölkerung: Ergebnisse der MONICA -Augsburg-Studien 1985-1994. Diabetes und Stoffwechsel 8: 11-21, 1999
13. Manicardi V, Camellini L, Beollodi G et al.: Evidence for an association of high blood pressure and hyperinsulinaemia in obese man. J Clin Endocrinol Metab 62: 1302-1304, 1986
14. Mitchell BD, Stern MP, Haffner SM et al.: Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites: The San Antonio Heart Study. Am J Epidemiol 131: 423-433, 1990.
15. Modan M, Halkin H, Almay S et al.: Hyperinsulinaemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75: 809-817, 1985
16. Mykkänen L, Haffner SM, Rönnemaa T et al.: Is there a sex difference in the association of plasma insulin level and insulin sensitivity with serum lipids and lipoproteins? Metabolism 43: 523-528, 1994
17. Panzram G: Mortality survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 30: 123-131, 1987
18. Panzram G, Zabel-Langhennig R: Prognosis of diabetes mellitus in a geographically defined population. Diabetologia, 20: 387-91, 1981
19. Ritz E, Stefanski A: Diabetic nephropathy in type II diabetes. Amer J Kidn Dis 27: 167-194, 1996
20. Ritz E, Bergis K, Strojek K, Grzeszczak W: Verlauf und Therapie der Nephropathie bei Typ II-Diabetes. Diabetes und Stoffwechsel 6: 151-156, 1997
21. Saad ME, Lillioja S, Nyomba BL et al.: Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324: 733-739, 1991
22. Saad MF, Knowler WC, Pettitt DJ et al.: Insulin and hypertension: relationship to obesity and glucose intolerance in Pima Indians. Diabetes 39: 1430-1435, 1990
23. Salomaa VV, Tuomilehto J, Jauhiainen M et al.: Hypertriglyceridaemia in different degrees of glucose intolerance in a Finnish population-based study. Diabetes Care 15: 657-665, 1992
24. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial: Diabetes Care 16: 434-444, 1993
25. Standl E, Stiegler H: Microalbuminuria in a random cohort of recently diagnosed type 2 diabetic patients in the greater Munich area. Diabetologia 36: 1017-1020, 1993
26. Stern MP: Diabetes and cardiovascular disease - the common soil hypothesis. Diabetes 44: 369-374, 1995
27. Taskinen MR: Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 6: 53-160, 1995
28. The Hypertension in Diabetics Study Group: Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 11: 309-317, 1993
29. Turner R, Cull C, Holman R: United Kingdom Prospective Diabetes Study 17: A 9-years update of a randomised controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 124: 136-142, 1996
30. Uhlbig MW, Kampik A, Hamilton AMP: Diabetische Retinopathie. Epidemiologie, Risikofaktoren und Stadieneinteilung. Ophtalmologe 90: 197-209, 1993
31. UK Prospective Diabetes Study Group: UKPDS 38: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 317: 703-713, 1998
32. Walters DP, Gatling W, Houston AC, Mullee MA, Julious SA, Hill RD: Mortality in diabetic subjects: An eleven-year follow-up of a community based population. Diabet Med 11: 968-973, 1994
33. Ziegler D, Gries FA: Klinik, Pathogenese und Therapie der diabetischen Neuropathie. Akt Endokr Stoffw 13: 140-150, 1992